News

A first-of-its-kind artificial intelligence-based neural network can rapidly analyze and interpret millions of cells from a patient sample, predicting molecular changes in the tissue.

A recent study has made significant progress in uncovering the microscopic mechanism behind heavy-ion cancer therapy.

Researchers find that tumor stem cells became less able to proliferate and invade tissues when gene editing blocked the production of the prion protein; the results suggest that the molecule could be a therapeutic target.

Researchers uncover new insights into the molecular mechanisms of ADAR1, a protein that regulates RNA-induced immune responses. Their findings could open new pathways for treating autoimmune diseases and enhancing cancer immunotherapy.

Research found that both muscle strength and cardiorespiratory fitness had a significant impact to lower the risk of all-cause and cancer-specific mortality in patients with any form of cancer and stage.

New research finds, adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models.

In a recent study, scientists not only show how cancer hijacks this tightly regulated splicing and rearranging of RNA but also introduce a potential therapeutic strategy that could slow or even shrink aggressive and hard-to-treat tumors.

Researchers from the VIB-KU Leuven Center for Cancer Biology, in collaboration with other scientists, have discovered a way to enhance the immune system's ability to fight cancer by reprogramming T-cell metabolism.

Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ‘switch’ to help it spread, revealing a potential new treatment strategy for this highly aggressive disease.

Avapritinib, an FDA-approved drug used to treat other types of cancer, also decreases aggressive gliomas in animal models and in an initial cohort of patients with high-grade glioma.